生物電力醫療的世界市場佔有率的分析:各終端用戶，各用途，各設備類型，各產品 - 產業的成長與需求預測(～2030年)

全球生物電力醫療的市場規模，從2022年的215億3,210萬美元到2030年達到323億4,580萬美元，預計成長5.2％。

本報告提供全球生物電力醫療市場相關調查分析，市場動態，各地區與市場區隔的市場收益，競爭情形等資訊。

目錄

第1章 調查的範圍

第2章 調查手法

第3章 摘要整理

第4章 產業的專家/KOL的迴響

第5章 市場指標

第6章 產業預測

• 市場動態
  • 趨勢
  • 促進因素
  • 阻礙因素/課題
  • 促進因素/阻礙因素的影響的分析
• COVID-19影響
• 波特的五力分析

第7章 全球市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)
• 市場收益:各地區(2017年～2030年)

第8章 北美市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)
• 市場收益:各國(2017年～2030年)

第9章 歐洲市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)
• 市場收益:各國(2017年～2030年)

第10章 亞太地區市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)
• 市場收益:各國(2017年～2030年)

第11章 南美市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)
• 市場收益:各國(2017年～2030年)

第12章 中東、非洲市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)
• 市場收益:各國(2017年～2030年)

第13章 美國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第14章 加拿大市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第15章 德國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第16章 法國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第17章 英國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第18章 義大利市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第19章 西班牙市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第20章 日本市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第21章 中國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第22章 印度市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第23章 澳洲市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第24章 韓國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第25章 巴西市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第26章 墨西哥市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第27章 沙烏地阿拉伯市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第28章 南非市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第29章 阿拉伯聯合大公國市場

• 概要
• 市場收益:各終端用戶(2017年～2030年)
• 市場收益:各用途(2017年～2030年)
• 市場收益:各設備類型(2017年～2030年)
• 市場收益:各產品(2017年～2030年)

第30章 競爭情形

• 市場企業與其產品的清單
• 主要企業的競爭基準
• 主要企業的產品基準
• 最近的策略性發展

第31章 企業簡介

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• Cochlear Limited
• Nevro Corp.
• Axonics Inc.
• Second Sight Medical Products Inc.
• electroCore Inc.
• Sonova Holding AG
• Biowave Limited
• MicroPort Scientific Corporation
• SetPoint Medical Corporation
• Sky Medical Technology
• Neuronetics Inc.

第32章 附錄

The value of the bioelectric medicine market was USD 21,532.1 million in 2022, and it will power at a rate of 5.2% in the future, to touch USD 32,345.8 million by 2030, as claimed by P&S Intelligence in its latest report.

Implantable Cardioverter Defibrillators Are Most Used

Implantable cardioverter defibrillators are the most used of all the products, because of their extensive range of applications. Their electrical stimulation capability makes them necessary for the treatment of atrial fibrillation, ventricular tachycardia, and atrial flutter.

Furthermore, they are employed in conjunction with other treatments, including medications or surgery.

The increasing occurrence of cardiac arrests and neurological ailments in the elderly population is pushing the growth of this category.

This part of society has a mounting requirement for implantable devices, including cardioverter defibrillators, deep-brain stimulators, cardiac pacemakers, and spinal cord stimulators.

Bioelectric Medicine Need Highest among Arrhythmia Patients

The arrhythmia category dominates the industry with around 60% of the revenue, and it will attain the highest CAGR in the future. This is because of the growing patient pool with the issue of arrhythmias, which widely uses implantable cardioverter defibrillators and cardiac pacemakers.

Moreover, several players are stressing over the increase of their business prospects, via collaborations, mergers, and partnerships, which will allow them to upgrade their research scope too.

Bioelectric Medicine Demand Is Highest in North America

North America had the largest revenue share, of above 40%, in the past, because of the high R&D investments, rising acceptance of technologically progressive devices, existence of major players, and large hospital count. Furthermore, the increasing healthcare spending is a key factor powering the regional industry.

Moreover, APAC will grow the fastest because of the increasing prevalence of numerous health ailments, including, Alzheimer's disease, epilepsy, spinal cord injuries, and cardiac arrhythmias; increasing government expenditure on the healthcare infrastructure, and wide accessibility of clinical labs and new diagnostic technologies.

Increasing Acceptance of Implantable Electroceutical Devices

The implantable electroceutical devices category had the largest share, of about 80%, in the past. This is mainly credited to the increasing prevalence of numerous cardiovascular and neurological illnesses and the increasing count of product approvals.

Hospitals To Grow Fastest as End Users

Hospitals will have the fastest growth, of around 7%, in the years to come. This will be because of the availability of cutting-edge devices for the detection and treatment of neurological and hearing ailments and skilled healthcare providers at these institutions.

Several chronic ailments, for example, Alzheimer's, arrhythmias, epilepsy, chronic pain, and retinitis pigmentosa, result in the hospitalization of the patient. In 2022, as per the Alzheimer's Association, about 6.5 million Americans aged over 65 years and about 73% of those aged 75 or more had Alzheimer's.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segment
  • 1.4.1. Market size breakdown, by end user
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by device type
  • 1.4.4. Market size breakdown, by product
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

• 6.1. Market Dynamics
  • 6.1.1. Trends
  • 6.1.2. Drivers
  • 6.1.3. Restraints/challenges
  • 6.1.4. Impact analysis of drivers/restraints
• 6.2. Impact of COVID-19
• 6.3. Porter's Five Forces Analysis
  • 6.3.1. Bargaining power of buyers
  • 6.3.2. Bargaining power of suppliers
  • 6.3.3. Threat of new entrants
  • 6.3.4. Intensity of rivalry
  • 6.3.5. Threat of substitutes

Chapter 7. Global Market

• 7.1. Overview
• 7.2. Market Revenue, by End User (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Device Type (2017-2030)
• 7.5. Market Revenue, by Product (2017-2030)
• 7.6. Market Revenue, by Region (2017-2030)

Chapter 8. North America Market

• 8.1. Overview
• 8.2. Market Revenue, by End User (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Device Type (2017-2030)
• 8.5. Market Revenue, by Product (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. Europe Market

• 9.1. Overview
• 9.2. Market Revenue, by End User (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Device Type (2017-2030)
• 9.5. Market Revenue, by Product (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. APAC Market

• 10.1. Overview
• 10.2. Market Revenue, by End User (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Device Type (2017-2030)
• 10.5. Market Revenue, by Product (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. LATAM Market

• 11.1. Overview
• 11.2. Market Revenue, by End User (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Device Type (2017-2030)
• 11.5. Market Revenue, by Product (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. MEA Market

• 12.1. Overview
• 12.2. Market Revenue, by End User (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by Device Type (2017-2030)
• 12.5. Market Revenue, by Product (2017-2030)
• 12.6. Market Revenue, by Country (2017-2030)

Chapter 13. U.S. Market

• 13.1. Overview
• 13.2. Market Revenue, by End User (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by Device Type (2017-2030)
• 13.5. Market Revenue, by Product (2017-2030)

Chapter 14. Canada Market

• 14.1. Overview
• 14.2. Market Revenue, by End User (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by Device Type (2017-2030)
• 14.5. Market Revenue, by Product (2017-2030)

Chapter 15. Germany Market

• 15.1. Overview
• 15.2. Market Revenue, by End User (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by Device Type (2017-2030)
• 15.5. Market Revenue, by Product (2017-2030)

Chapter 16. France Market

• 16.1. Overview
• 16.2. Market Revenue, by End User (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by Device Type (2017-2030)
• 16.5. Market Revenue, by Product (2017-2030)

Chapter 17. U.K. Market

• 17.1. Overview
• 17.2. Market Revenue, by End User (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by Device Type (2017-2030)
• 17.5. Market Revenue, by Product (2017-2030)

Chapter 18. Italy Market

• 18.1. Overview
• 18.2. Market Revenue, by End User (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by Device Type (2017-2030)
• 18.5. Market Revenue, by Product (2017-2030)

Chapter 19. Spain Market

• 19.1. Overview
• 19.2. Market Revenue, by End User (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by Device Type (2017-2030)
• 19.5. Market Revenue, by Product (2017-2030)

Chapter 20. Japan Market

• 20.1. Overview
• 20.2. Market Revenue, by End User (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by Device Type (2017-2030)
• 20.5. Market Revenue, by Product (2017-2030)

Chapter 21. China Market

• 21.1. Overview
• 21.2. Market Revenue, by End User (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by Device Type (2017-2030)
• 21.5. Market Revenue, by Product (2017-2030)

Chapter 22. India Market

• 22.1. Overview
• 22.2. Market Revenue, by End User (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by Device Type (2017-2030)
• 22.5. Market Revenue, by Product (2017-2030)

Chapter 23. Australia Market

• 23.1. Overview
• 23.2. Market Revenue, by End User (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by Device Type (2017-2030)
• 23.5. Market Revenue, by Product (2017-2030)

Chapter 24. South Korea Market

• 24.1. Overview
• 24.2. Market Revenue, by End User (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by Device Type (2017-2030)
• 24.5. Market Revenue, by Product (2017-2030)

Chapter 25. Brazil Market

• 25.1. Overview
• 25.2. Market Revenue, by End User (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by Device Type (2017-2030)
• 25.5. Market Revenue, by Product (2017-2030)

Chapter 26. Mexico Market

• 26.1. Overview
• 26.2. Market Revenue, by End User (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by Device Type (2017-2030)
• 26.5. Market Revenue, by Product (2017-2030)

Chapter 27. Saudi Arabia Market

• 27.1. Overview
• 27.2. Market Revenue, by End User (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by Device Type (2017-2030)
• 27.5. Market Revenue, by Product (2017-2030)

Chapter 28. South Africa Market

• 28.1. Overview
• 28.2. Market Revenue, by End User (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by Device Type (2017-2030)
• 28.5. Market Revenue, by Product (2017-2030)

Chapter 29. U.A.E. Market

• 29.1. Overview
• 29.2. Market Revenue, by End User (2017-2030)
• 29.3. Market Revenue, by Application (2017-2030)
• 29.4. Market Revenue, by Device Type (2017-2030)
• 29.5. Market Revenue, by Product (2017-2030)

Chapter 30. Competitive Landscape

• 30.1. List of Market Players and Their Offerings
• 30.2. Competitive Benchmarking of Key Players
• 30.3. Product Benchmarking of Key Players
• 30.4. Recent Strategic Developments

Chapter 31. Company Profiles

• 31.1. Medtronic plc
  • 31.1.1. Business overview
  • 31.1.2. Product and service offerings
  • 31.1.3. Key financial summary
• 31.2. Abbott Laboratories
  • 31.2.1. Business overview
  • 31.2.2. Product and service offerings
  • 31.2.3. Key financial summary
• 31.3. Boston Scientific Corporation
  • 31.3.1. Business overview
  • 31.3.2. Product and service offerings
  • 31.3.3. Key financial summary
• 31.4. LivaNova PLC
  • 31.4.1. Business overview
  • 31.4.2. Product and service offerings
  • 31.4.3. Key financial summary
• 31.5. Cochlear Limited
  • 31.5.1. Business overview
  • 31.5.2. Product and service offerings
  • 31.5.3. Key financial summary
• 31.6. Nevro Corp.
  • 31.6.1. Business overview
  • 31.6.2. Product and service offerings
  • 31.6.3. Key financial summary
• 31.7. Axonics Inc.
  • 31.7.1. Business overview
  • 31.7.2. Product and service offerings
  • 31.7.3. Key financial summary
• 31.8. Second Sight Medical Products Inc.
  • 31.8.1. Business overview
  • 31.8.2. Product and service offerings
  • 31.8.3. Key financial summary
• 31.9. electroCore Inc.
  • 31.9.1. Business overview
  • 31.9.2. Product and service offerings
  • 31.9.3. Key financial summary
• 31.10. Sonova Holding AG
  • 31.10.1. Business overview
  • 31.10.2. Product and service offerings
  • 31.10.3. Key financial summary
• 31.11. Biowave Limited
  • 31.11.1. Business overview
  • 31.11.2. Product and service offerings
• 31.12. MicroPort Scientific Corporation
  • 31.12.1. Business overview
  • 31.12.2. Product and service offerings
  • 31.12.3. Key financial summary
• 31.13. SetPoint Medical Corporation
  • 31.13.1. Business overview
  • 31.13.2. Product and service offerings
• 31.14. Sky Medical Technology
  • 31.14.1. Business overview
  • 31.14.2. Product and service offerings
• 31.15. Neuronetics Inc.
  • 31.15.1. Business overview
  • 31.15.2. Product and service offerings
  • 31.15.3. Key financial summary

Chapter 32. Appendix

• 32.1. Abbreviations
• 32.2. Sources and References
• 32.3. Related Reports

LIST OF FIGURES

• FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
• FIG 2 RESEARCH METHODOLOGY
• FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
• FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
• FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
• FIG 6 DATA TRIANGULATION APPROACH
• FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)
• FIG 8 GLOBAL BIOELECTRIC MEDICINE MARKET SUMMARY
• FIG 9 BARGAINING POWER OF BUYERS
• FIG 10 BARGAINING POWER OF SUPPLIERS
• FIG 11 THREAT OF NEW ENTRANTS
• FIG 12 INTENSITY OF RIVALRY
• FIG 13 THREAT OF SUBSTITUTES
• FIG 14 GLOBAL BIOELECTRIC MEDICINE MARKET SNAPSHOT
• FIG 15 GLOBAL BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 16 GLOBAL BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 17 GLOBAL BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 18 GLOBAL BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 19 MAJOR WORLDWIDE MARKETS FOR BIOELECTRIC MEDICINE, $M
• FIG 20 NORTH AMERICA BIOELECTRIC MEDICINE MARKET SNAPSHOT
• FIG 21 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 22 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 23 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 24 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 25 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017-2030)
• FIG 26 EUROPE BIOELECTRIC MEDICINE MARKET SNAPSHOT
• FIG 27 EUROPE BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 28 EUROPE BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 29 EUROPE BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 30 EUROPE BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 31 EUROPE BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017-2030)
• FIG 32 APAC BIOELECTRIC MEDICINE MARKET SNAPSHOT
• FIG 33 APAC BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 34 APAC BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 35 APAC BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 36 APAC BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 37 APAC BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017-2030)
• FIG 38 LATAM BIOELECTRIC MEDICINE MARKET SNAPSHOT
• FIG 39 LATAM BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 40 LATAM BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 41 LATAM BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 42 LATAM BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 43 LATAM BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017-2030)
• FIG 44 MEA BIOELECTRIC MEDICINE MARKET SNAPSHOT
• FIG 45 MEA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 46 MEA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 47 MEA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 48 MEA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 49 MEA BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017-2030)
• FIG 50 U.S. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 51 U.S. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 52 U.S. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 53 U.S. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 54 CANADA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 55 CANADA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 56 CANADA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 57 CANADA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 58 GERMANY BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 59 GERMANY BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 60 GERMANY BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 61 GERMANY BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 62 FRANCE BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 63 FRANCE BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 64 FRANCE BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 65 FRANCE BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 66 U.K. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 67 U.K. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 68 U.K. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 69 U.K. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 70 ITALY BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 71 ITALY BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 72 ITALY BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 73 ITALY BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 74 SPAIN BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 75 SPAIN BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 76 SPAIN BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 77 SPAIN BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 78 JAPAN BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 79 JAPAN BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 80 JAPAN BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 81 JAPAN BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 82 CHINA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 83 CHINA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 84 CHINA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 85 CHINA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 86 INDIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 87 INDIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 88 INDIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 89 INDIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 90 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 91 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 92 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 93 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 94 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 95 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 96 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 97 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 98 BRAZIL BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 99 BRAZIL BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 100 BRAZIL BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 101 BRAZIL BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 102 MEXICO BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 103 MEXICO BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 104 MEXICO BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 105 MEXICO BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 106 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 107 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 108 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 109 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 110 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 111 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 112 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 113 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 114 U.A.E. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017-2030)
• FIG 115 U.A.E. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017-2030)
• FIG 116 U.A.E. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017-2030)
• FIG 117 U.A.E. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017-2030)
• FIG 118 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 119 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 120 BOSTON SCIENTIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 121 LIVANOVA PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 122 COCHLEAR LIMITED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 123 NEVRO CORP. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 124 AXONICS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 125 SECOND SIGHT MEDICAL PRODUCTS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 126 ELECTROCORE INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 127 SONOVA HOLDING AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 128 MICROPORT SCIENTIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
• FIG 129 NEURONETICS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)